FLUSTRAMINE A

ID: ALA538411

Max Phase: Preclinical

Molecular Formula: C21H29BrN2

Molecular Weight: 389.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CC(C)(C)[C@@]12CCN(C)[C@@H]1N(CC=C(C)C)c1cc(Br)ccc12

Standard InChI:  InChI=1S/C21H29BrN2/c1-7-20(4,5)21-11-13-23(6)19(21)24(12-10-15(2)3)18-14-16(22)8-9-17(18)21/h7-10,14,19H,1,11-13H2,2-6H3/t19-,21-/m1/s1

Standard InChI Key:  AJYIZQUARKFPEC-TZIWHRDSSA-N

Associated Targets(non-human)

Voltage-gated potassium channel subunit Kv1.1 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Voltage-gated potassium channel subunit Kv1.4 31 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sodium channel protein type II alpha subunit 191 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.38Molecular Weight (Monoisotopic): 388.1514AlogP: 5.35#Rotatable Bonds: 4
Polar Surface Area: 6.48Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.47CX LogP: 6.04CX LogD: 5.99
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.64Np Likeness Score: 1.95

References

1. Peters L, König GM, Terlau H, Wright AD..  (2002)  Four new bromotryptamine derivatives from the marine bryozoan Flustra foliacea.,  65  (11): [PMID:12444689] [10.1021/np0105984]

Source